Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

Behavioural Brain Research

Volumn 118, Issue 1, 2001, Pages 61-65

  Cossu, Gregorio ^a   Ledent, Catherine ^b   Fattore, Liana ^a   Imperato, Assunta ^c   Böhme, Georg A ^c   Parmentier, Marc ^b   Fratta, Walter ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c SANOFI   (France)

Author keywords

Amphetamine; CB1 receptor; CB1 receptor knockout mice; Cocaine; Intravenous self administration; Morphine; Nicotine; Reward

Indexed keywords

AMPHETAMINE; CANNABINOID; CANNABINOID RECEPTOR; COCAINE; DOPAMINE UPTAKE INHIBITOR; DRUG RECEPTOR; MORPHINE; NARCOTIC AGENT; NICOTINE; NICOTINIC AGENT; CANNABINOID 1 RECEPTOR; DEXAMPHETAMINE;

ADDICTION; ANIMAL; ARTICLE; DRUG EFFECT; MALE; METABOLISM; MOUSE; MOUSE MUTANT; REWARD; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SUBSTANCE ABUSE;

AMPHETAMINE; ANIMALS; BEHAVIOR, ADDICTIVE; CANNABINOIDS; COCAINE; DOPAMINE UPTAKE INHIBITORS; MALE; MICE; MICE, KNOCKOUT; MORPHINE; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REWARD;

EID: 0035824948     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00311-9     Document Type: Article

References (40)

1. Relationship between frequency and quantity of marijuana use and last year proxy dependence among adolescent and adult in the United States
2. The quasi-morphine withdrawal syndrome: Effect of cannabinol, cannabidiol and tetrahydrocannabinol
3. Marijuana. Pharmacological aspects of drug dependence
4. Reluctance of rats to drink hashish suspensions: Free choice and forced consumption, and the effects of hypothalamic stimulation
5. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area
6. Drug abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
7. Marijuana's interactions with brain reward systems: Update 1991
8. A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal dog
9. The cannabinoid receptor: Biochemical, anatomical and behavioural characterization
10. Evaluation of reinforcing capability of Delta-9-THC in rhesus monkeys
11. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
12. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
13. The calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice
14. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
15. Failure to obtain 'cannabis directed behavior' and abstinence syndrome in rats chronically treated with cannabis sativa extracts
16. Pharmacology and stereoselectively of structurally novel cannabinoids in mice
17. 9-tetrahydrocannabinol and CP 55, 940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys
18. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice
19. Self-administration of the cannabinoid receptor agonist WIN 55, 212-2 in drug-naive mice
20. Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice
21. 1 receptor knockout mice
22. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
23. Molecular characterization of a peripheral receptor for cannabinoids
24. 1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
25. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area
26. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
27. 9-tetrahydrocannabinol-induced analgesia in mice
28. 9-tetrahydrocannabinol-induced analgesia by morphine in mice: Involvment of μ and k opioid receptors
29. Inhibition of opioid-degrading enzymes potentiates Delta9-tetrahydrocannabinol-induced antinociception in mice
30. 1 knock-out mice
31. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
32. Epidemiology of illicit and abused drugs in the general population, emergency department drug-related episodes, and arrestees
33. 3H]dopamine release by nicotine in rat nucleus accumbens
34. Modulation of rat brain cannabinoid receptors after chronic morphine treatment
35. Self-administration of delta-9-tetrahydrocannabinol by rats
36. 1 opioid receptor mechanism
37. 1 receptors
38. Intravenous self-administration of drugs in rats
39. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice
40. Blockade of cannabinoid-induced antinociception by nor-binaltorphimine, but not N, N-diallyl-tyrosine-aib-phenylalanine-leucine, ICI 174, 864 or naloxone in mice